Stock listing

ENTX Stock Price, News, Filings & Events — Entera Bio Ltd.

Selected listing: ENTX · BOATS · USD · US

This page tracks Entera Bio Ltd.'s ENTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ENTX:BOATS. ENTX:BOATS is the stock-level entry point for investors researching Entera Bio Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Entera Bio Ltd. is a public company traded under the ticker ENTX in the American market. The company has a market capitalization of approximately $101 million. Entera Bio focuses on developing oral drug delivery systems for biologics, aiming to improve patient outcomes and expand treatment options.

ENTX:BOATSUSDUSUpdated September 11, 2026
Entera Bio Ltd. logo
Ticker
ENTX:BOATS
Asset type
Stock
Market cap
$493.7M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Entera Bio Ltd. ENTX:BOATS stock context

This page tracks Entera Bio Ltd.'s ENTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ENTX:BOATS. ENTX:BOATS is the stock-level entry point for investors researching Entera Bio Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Entera Bio Ltd. is a public company traded under the ticker ENTX in the American market. The company has a market capitalization of approximately $101 million. Entera Bio focuses on developing oral drug delivery systems for biologics, aiming to improve patient outcomes and expand treatment options.

Latest news from Entera Bio Ltd.

All Entera Bio Ltd. news →

Entera Bio Ltd. earnings calls

Research Entera Bio Ltd.

Alternate listings